Finanzen von AdvanSix Inc. (ASIX)ASIXAdvanSix Inc.

AdvanSix Inc. (ASIX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Plant Nutrients, accounting for 34.8% of total sales, equivalent to $140.63M. Other significant revenue streams include Chemical Intermediates and Nylon. Understanding this composition is critical for investors evaluating how ASIX navigates market cycles within the Specialty Chemicals industry.

Evaluating the bottom line, AdvanSix Inc. maintains a gross margin of 7.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.15%, while the net margin is 0.77%. These profitability ratios, combined with a Return on Equity (ROE) of -2.19%, provide a clear picture of how effectively ASIX converts its operational activities into shareholder value.

In the context of the broader market, ASIX competes directly with industry leaders such as GEVO and VHI. With a market capitalization of $460.10M, it holds a leading position in the sector. When comparing efficiency, ASIX's gross margin of 7.38% stands against GEVO's 42.58% and VHI's 19.82%. Such benchmarking helps identify whether AdvanSix Inc. is trading at a premium or discount relative to its financial performance.

AdvanSix reported a significant drop in net income, with a loss of $15.5 million in Q1 2026 and a gross margin of only 0.94% in Q1 2026, indicating severe profitability issues. The total revenue for Q2 2026 was $421 million, but the overall trend shows volatility and inconsistency in earnings.